--2025/Q1-- / 100.000K--
--2024/Q4-- / 30.000K--
Nov 14, 20242024/Q30.000 / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
US Stock MarketDetailed Quotes
INO Inovio Pharmaceuticals
- 1.8400
- -0.0050-0.27%
Close Dec 20 16:00 ET
- 1.8487
- +0.0087+0.47%
Post 19:59 ET
66.42MMarket Cap-0.42P/E (TTM)
1.8500High1.7500Low1.45MVolume1.8300Open1.8450Pre Close2.65MTurnover4.27%Turnover RatioLossP/E (Static)36.10MShares14.748052wk High0.90P/B62.34MFloat Cap1.740052wk Low--Dividend TTM33.88MShs Float2352.0000Historical High--Div YieldTTM5.42%Amplitude1.7400Historical Low1.8280Avg Price1Lot Size
Inovio Pharmaceuticals Key Stats
Inovio Pharmaceuticals Q3 2024 Earnings Date
Currency：USDNov 14, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 104.50K | 0 | -104.50K |
| Miss Est. | -73.10% | -100.00% | -100.00% |
| EPS | -1.15 | -0.89 | +0.26 |
| Beat Est. | +26.28% | +41.45% | +22.60% |
Analyst Rating
Nov 30, 2024
Inovio Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Inovio Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data
